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Several analogues of beat-stable enterotoxins (ST, and ST,) produced by enterotoxigenic Escherichia cdi 
were synthesized. Peptides (ST&-181 and ST&171) consisting of 13 amino acid residues from the Cys resi- 
due near the N-terminus to the Cys residue near the C-terminus and linked by three disubide bonds had 
the same biological and immunological properties as native ST, and ST,, respectively. The results indicated 
that the sequence with the 13 amino acid residues and three disulfide linkages i  essential for full biological 
activity of ST. 
1. INTRODUCTr~N 
Various strains of enterotoxigenic Escherichia 
coli (ETEC) from animal hosts produce 
heterologous heat-stable enterotoxins (ST) that 
cause watery diarrhea in man and various domestic 
animals [I]. ST is reported to stimulate the 
guanylate cyclase-cyclic GMP system and raise the 
level of cyclic GMP in ST-sensitive cells 12-57, 
although the biochemical processes involved in 
development of watery diarrhea are still unknown, 
Recentfy, we [6-g] and others [9-l 1] isolated and 
purified two kinds of STs from human and porcine 
strains of ETEC and determined their amino acid 
sequences. As shown in fig. 1, the sequences of the 
two STs from the Tyr residue near the N-terminus 
to the Tyr residue at the C-terminus are identical 
except at position 4 from the C-terminus. We syn- 
thesized STh and ST, chemically and confirmed 
that they have the same biolo~ic~ and 
* To whom correspondence should be addressed 
physi~oc~~mic~ properties as native STh and ST,,, 
respectively [12-141. Furthermore, we found that 
5 and 4 N-terminal amino acid residues of STt, and 
ST,, respectively, are not essential for expression 
of the enterotoxigenic activity of ST in suckling 
mice or for stability on heating [ 15,161. The toxic 
activities of STh and ST, were also found to be 
neutralized by homologous anti-ST antisera raised 
in rabbits, and to be cross-neutralized by 
heterofogous anti-ST antisera II?]. These findings 
indicated that the common sequences are impor- 
tant for expression of the biological and im- 
munological activities and heat-stability of ST. 
Thus, it seemed interesting to elucidate the 
minimum structure of ST necessary for expression 
of full biological activity. 
This paper reports the preparation of several 
analogues of STb and ST, lacking the C-terminal 
Tyr residue. We found that the sequence from the 
Cys residue near the N-terminus to the Cys residue 
near the C-terminus with 3 disulfide linkages 
showed full biologicat activity. 
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STha) Asn-Ser-Ser-Asn-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr 
ST;) Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr 
1 5 10 15 
Fig. 1. Amino acid sequences of ST: (a) from [7] and (b) from [8,10,11]. Underlined regions indicate sequence homology 
in the two STs. 
2. MATERIALS AND METHODS 
2.1. Preparation of ST& and Sl;, a~aIogue5 
STi, and ST, analogues (STh[l-191, STh[5-191, 
ST,&-191, ST&-181, ST,[4-181, and ST,[5-181) 
were synthesized by reported procedures 
[12,14,16,18]. Samples of 2OOgg of these STh and 
ST, analogues were dissolved in 200 ~1 of 0.1 M 
pyridine-acetate, at pH 8.1, and treated with car- 
boxypeptidase B (Boehringer, Mannheim) at a 
substrate-enzyme ratio of 33: 1 at 37°C for 16 h. 
This commercial enzyme released C-terminal 
neutral amino acid residues. The digestion was 
stopped by addition of glacial acetic acid, digests 
were applied directly to a reversed-phase column 
of HPLC under the conditions described below, 
and peak fractions of eluate were separated and 
lyophilized .
2.2. Chemical synthesis of STt,[6-181 
Protected linear peptide with the amino acid se- 
quence of STh[6-181 was synthesized by conven- 
tional methods, as described for the synthesis of 
STh[6-191 [15]. The protected peptide was treated 
with anhydrous liquid HF and air-oxidized, the 
air-oxidized peptide being then purified by ion- 
exchange and high-performance liquid chroma- 
tographies. 
2.3. High-performance liquid chromatography 
(HPLC) 
HPLC was performed on a column (6 x 
150 mm) of YMC-ODS S-5 (Yamamura Chemical 
Laboratory Co., Japan). The column was 
equilibrated with 10% acetonitrile containing 
0.05% trifluoroacetic acid (pH 2.35) and then the 
sample solution was applied. The column was 
developed with a linear gradient of IO-40% 
acetonitrile in 0.05~0 trifluoroacetic acid (pH 2.35) 
with increase in acetonitrile of l%/min at a flow 
rate of 1 ml/min. 
2.4. Biological assay 
Enterotoxigenic activity was assayed by measur- 
ing the amount of sample required to cause fluid 
accumulation in the intestine of 2-4-day-old suck- 
ling mice 4 h after its administration, as in [6]. The 
fluid accumulation ratio of each animril was 
calculated as the ratio of the weight of the entire 
intestine to that of the rest of the body. The 
minimal amount of sample (minimum effective 
dose) giving a fluid accumulation ratio of over 0.09 
was designated as 1 mouse unit. Neutralization of 
analogues of ST with anti-native ST antiserum was 
examined as in [17]. 
2-S. FAB mass spectro~etry 
Mass spectra were recorded with a Jeol JMS- 
HXlOO double-focusing mass spectrometer 
equipped with an FAB ion source, as in 181. 
2.6. Heat stability 
Synthetic peptides were tested for heat stability 
by HPLC as in [15]. 
3. RESULTS AND DISCUSSION 
To elucidate the minimum structure of ST essen- 
tial for its full biological activity and to determine 
the effect of the C-terminal Tyr residue on ST ac- 
tivity and heat stability, we first prepared several 
analogues of STh and ST, lacking a C-terminal Tyr 
residue, as shown in table 1. These peptides were 
obtained by treatment of STh and ST, analogues 
[16,18] with carboxypeptidase and were finally 
purified to homogeneity by reverse-phase HPLC. 
An example of the results is shown in fig.2. The 
products were analyzed by FAB mass spectrometry 
and by amino acid analysis in the acid 
hydrolysates, as summarized in table 2. The 
biological activity of all the analogues of ST was 
almost the same within the limits of experimental 
error as native ST in the suckling mouse assay, as 
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Table 2 
Amino acid corn~s~ti~~s and mass vafues of synthetic anabgues of ST” 
sT,iEr-rs1 sT$s-tsZ s’ih&-f?j = [6-r& it sT,lt-?;r3 ST+4473 STpf5-171 
3.00@f I.Oxl[l) l.crs(l> f.#3(1f 1*94(Z) l.OE(T) i.Wl(ff 
0.95(11 1.02(l) l.03jlf l.Olflf O"98petlf 
1.91(2) 
1.07(l) l,Ql(l) 1.03(l) 1.020) 1.01(1) 1.03(l) 1.06(l) 
1.13(l) a.9711) l.DO(l) 1.03(l) r.ostr1 1.26(l) 1.30(l) 
1.05(l) l.WlI 1*01(l) 1.02(l) b.SS(l) 1.09(l) 0.990) 
1.00(l) l.OO(l~ l.OO(l~ 3.OOIl) 2.0012) 2.00(2) 2.00(2) 
5.53(6) 5,89(6) 5.33(6) 5.4616) S.52fSl 6.00(6) 5.67(6) 
1.0?(l) l.OSIlI 1.04f7) l.asIl) 1.07(l) l.iOIl) l.oof~) 
&97flf f3.96(1) 0.94fl) 0.96flI 
r.i%fl) 
I855.6 1476.4 1313.0 3313.5 1808.5 1446.5 fPG3.4 
(lG73.61 fl476.4) 0313.4) 0313.41 flW*6) fl446.41 (1283.3) 
a Values were caIculated as moI/mol of Ala; numbers in parentheses indicate theoretical values 
b This peptide was synthesized chemically 
amino acid residues, we synthesized sTh[6-181 
chemically by the scheme reported in /15], ST’s are 
linked ~~tr~o~e~u~ar~y by 3 disurifide bonds, 
aItho~gh the exact positions of the d&&fide bonds 
have not yet been det~rrn~ned~ To determine 
whether synthetic ST&%-181 has the same disuIfide 
linkages as native STbr we compared synthetic 
ST&G-181 with that with the same secondary struc- 
ture as native STh [18] obtained from STh[6-191, 
by enzymatic digestion. This peptide had the same 
retention time on HPLC (fig.2) and the same 
biolagical activity as STh[6-181 obtained from 
STb[6-191 by carboxypeptidase digestion. The 
peptide can be easily synthesized in large quan- 
tities, because it has fess amino acid residues than 
native toxin and is formed in good yield from a 
sy~tb~t~~ linear peptide by air ox~d~t~o~ [18], This 
peptide wiII be of practical use in an ST-enzyme- 
linked immunoassay (ELISA) [ l9J. 
Previously, we synthesized a peptide with the 
amino acid sequence of ST proposed by Chan and 
Giannella [9], in which the Asn and Tyr residues at 
position 11 and the C-terminus of STF, are replaced 
by Tyr and Asn, respectively. The. peptide had 
30-40-times kss enterotoxigenic activity than the 
native toxin 1141, suggesting that this substitutioti 
reduces the biological activity of ST part&&y, but 
not ~ornp~~e~y. The residue at ~s~t~~~ 4 from the 
C-terminus of ST is Thr in STI, and Ala in STxr, but 
this difference does not influence the activity of 
ST. On the other hand, the reduction of disulfide 
linkages abolished compfetety the toxic activity [9] e 
Thus, we conclude from this wurk that at least 13 
amino acid residues from the Cys residue neaf the 
N-terminus to the Cys residue near the C-terminus 
with 3 disulfide bonds are necessary for expression 
of the full biological activity of ST. 
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